Hiring.fm | Direct Job Opportunities from Top Employers

This position can be 100% remote.

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines.

At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary. Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.

The Senior Director, Technology Transactions & Commercial Contracts will play a key role enabling Dynavax’s strategic business and licensing transactions supporting the company’s business goals. This role will be highly visible and will directly contribute to Dynavax’s success. This role is responsible for building strong relationships across the company, including with the research and development, business development, technical operations, project management, clinical teams and IT, and will serve as a trusted business adviser. The position will report to the Senior Vice President, General Counsel and Vice President, Intellectual Property (as appropriate).